Anika Therapeutics, Inc. (NASDAQ:ANIK) Q1 2024 Earnings Call Transcript

Anika Therapeutics, Inc. (NASDAQ:ANIK) Q1 2024 Earnings Call Transcript May 8, 2024

Anika Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.30712 EPS, expectations were $-0.19. Anika Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).

Operator: Good evening, ladies and gentlemen, and welcome to Anika’s First Quarter 2024 Earnings Conference Call. [Operator Instructions] I would like to...